Mirati Therapeutics Inc. buy Midas
Start price
10.12.20
/
50%
€197.70
Target price
10.12.21
-
Performance (%)
-27.04%
End price
09.04.21
€144.25
Summary
This prediction ended on 09.04.21 with a price of €144.25. The price of Mirati Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.04%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Mirati Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1,84 % | 1,39 % | 8,65 % | 62,63 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % | 27,82 % | 85,63 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % | 51,81 % | 76,25 % |
| iShares S&P 500 | 3,70 % | 1,58 % | 24,09 % | 69,87 % |
Comments by Midas for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Buy Mirati Therapeutics Inc.